Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Interleukin 6
(section)
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Notable studies== *1998, Interleukin-6 and Disease: Two Case Reports that Point to the Usefulness of Measuring Cytokine Levels in Clinical Settings<blockquote> Abstract - "Chronic fatigue syndrome has been associated with patterns of cytokine imbalances whose relevance to disease status remains to be documented. We present here two case reports that illustrate the relevance of measuring interleukin-6 levels in biological fluids in two clinical entities: hypothermia and Sjögren's syndrome. Further studies of this nature in extended patient populations will allow to discern the relevant contribution among the pleiotropy of roles of each particular cytokine in different clinical settings. It becomes apparent from the cases presented that the clinical manifestation of the imbalance in the expression of a particular cytokine is contingent upon the compartment where it occurs and upon levels of other cylokines. Similar studies will allow to define signature cytokine imbalances for each disease condition and may also shed light on thus far uncharacterized etiological agents."<ref name="PatarcaJ092">{{Cite journal | last = Patarca | first = Roberto | authorlink = Roberto Patarca-Montero | last2 = Fletcher | first2 = Mary Ann | authorlink2 = Mary Ann Fletcher | date = 1998-01-01 | title = Interleukin-6 and Disease | url = https://doi.org/10.1300/J092v04n01_07|journal=Journal of Chronic Fatigue Syndrome|volume=4|issue=1 | pages = 53–69|doi=10.1300/J092v04n01_07|issn=1057-3321|pmc=|pmid=|access-date=|quote=|via=}}</ref></blockquote> *2002, During acute influenza-like symptoms in 19 CFS patients and 10 normal controls an IL-6 challenge was administered: CFS somatic symptoms increased more rapidly in CFS patients compared with controls - cognitive impairment was not affected during the IL-6 challenge.<ref name="Arnold2002">{{Cite journal | last = Arnold | first = M.C. | authorlink = | last2 = Papanicolaou | first2 =D.A. | authorlink2 = | last3 = O'Grady | first3 = J.A. | authorlink3 = | last4 = Lotsikas | first4 = A. | authorlink4 = | last5 = Dale | first5 = J.K. | authorlink5 = | last6 = Straus | first6 = S.E. | authorlink6 = | last7 = Grafman | first7 = J. | date = Aug 2002 | title = Using an interleukin-6 challenge to evaluate neuropsychological performance in chronic fatigue syndrome | url = https://pubmed.ncbi.nlm.nih.gov/12214788/|journal=Psychological Medicine|volume=32|issue=6|pages=1075–1089|doi=10.1017/s0033291702006086|issn=0033-2917|pmc=|pmid=12214788|access-date=|quote=|via=}}</ref> *2016, [http://bmcimmunol.biomedcentral.com/articles/10.1186/s12865-016-0142-3 Illness progression in chronic fatigue syndrome: a shifting immune baseline]<ref name="BroderickL2016">{{cite journal | last1 = Russell | first1 = Lindsey| authorlink1 = | last2 = Broderick | first2 = Gordon | authorlink2 = Gordon Broderick | last3 = Taylor | first3 = Renee | authorlink3 = Renee Taylor | last4 = Fernandes | first4 = Henrique | authorlink4 = | last5 = Harvey | first5 = Jeanna| authorlink5 = Jeanna Harvey| last6 = Barnes | first6 = Zachary| authorlink6 = Zachary Barnes | last7 = Smylie | first7 = AnneLiese | authorlink7 = AnneLiese Smylie | last8 = Collado | first8 = Fanny | authorlink8 = Fanny Collado | last9 = Balbin | first9 = Elizabeth | author-link9 = Elizabeth Balbin | last10 = Katz | first10 = Ben | authorlink10 = Ben Katz | last11 = Klimas | first11 = Nancy| authorlink11 = Nancy Klimas | last12 = Fletcher | first12 = Mary Ann | authorlink12 = Mary Ann Fletcher| title = Illness progression in chronic fatigue syndrome: a shifting immune baseline | journal = BMC Immunology | volume = 17 | issue = 13 | date = Mar 10, 2016 | pmid = 26965484| doi = 10.1186/s12865-016-0142-3 | url = http://bmcimmunol.biomedcentral.com/articles/10.1186/s12865-016-0142-3 |pages=}}</ref> : These findings may serve as a robust biomarker: :: * [[Interleukin 1alpha|IL-1α]], higher in recently ill adolescent ME/CFS subjects, was progressively less important with duration. :: * IL-6, lower in early illness, higher for subjects ill for more than 2 years and over 18 years of age. :: * [[Interleukin 8|IL-8]], higher in the recently afflicted, lower for subjects ill for more than 2 years.
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
This page is a member of 2 hidden categories:
Category:All stub articles
Category:Stub pages last edited in 2023
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs